Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.
Pharm Res
; 39(11): 2745-2759, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35146591
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma
/
Carcinoma, Non-Small-Cell Lung
/
Nanostructures
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Pharm Res
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: